ClinVar Miner

Submissions for variant NM_005422.4(TECTA):c.5488G>A (p.Val1830Met)

gnomAD frequency: 0.00011  dbSNP: rs189181502
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Testing Center for Deafness, Department of Otolaryngology Head & Neck Surgery, Institute of Otolaryngology, Chinese PLA General Hospital RCV001002756 SCV000992398 likely benign Autosomal dominant nonsyndromic hearing loss 12 criteria provided, single submitter case-control
GeneDx RCV001664484 SCV001872922 uncertain significance not provided 2021-08-03 criteria provided, single submitter clinical testing Identified in a patient with hearing loss in published literature who also harbored a variant in the POU4F3 gene which the authors considered to be causative; the TECTA variant was observed in unaffected family members (He et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 21520338, 31554319, 9590290, 16718611, 28053790)
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV004789235 SCV005399205 likely benign Nonsyndromic genetic hearing loss 2020-10-19 criteria provided, single submitter clinical testing Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as 2-Likely benign. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. However, dominant negative has been suggested as a mechanism of disease for missense variants in this gene (OMIM). (N) 0108 - This gene is known to be associated with both recessive and dominant disease. This gene is associated with autosomal dominant and recessive deafness (OMIM). (N) 0200 - Variant is predicted to result in a missense amino acid change from valine to methionine (exon 17). (N) 0251 - Variant is heterozygous. (N) 0302 - Variant is present in gnomAD <0.001 for a dominant condition (v2: 104 Heterozygotes, 1 Homozygote). (P) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2: 1 Heterozygotes, 0 Homozygote). (N) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (N) 0600 - Variant is located in an annotated domain or motif. This variant is in the Zona pellucida domain (NCBI conserved domain). (N) 0705 - No comparable variants have previous evidence for pathogenicity. (N) 0806 - Moderate previous evidence of neutrality in unrelated individuals. This variant was reported in one individual with autosomal dominant nonsyndromic hearing loss but did not segregate with other affected family members (PMID: 28053790). (B) 1007 - No published functional evidence has been identified for this variant. (N) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign
CeGaT Center for Human Genetics Tuebingen RCV001664484 SCV005433814 uncertain significance not provided 2024-11-01 criteria provided, single submitter clinical testing TECTA: PM2
Labcorp Genetics (formerly Invitae), Labcorp RCV001664484 SCV005774283 likely benign not provided 2025-01-20 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.